Search - tctmd.com

Displaying 261 - 280 of 786

Sort: Relevancy | Date

Presentation EuroPCR 2018

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

Presenter: David Muller

May 25, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

Presentation EuroPCR 2018

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

Presenter: Mayra Guerrero

May 24, 2018

News Industry News

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

May 24, 2018

News Industry News

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

May 24, 2018

Presentation EuroPCR 2018

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Presenter: Simon Redwood

May 24, 2018

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

News Industry News

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

May 24, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

Presentation EuroPCR 2018

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Presenter: Francesco Bedogni

May 23, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

Presentation EuroPCR 2018

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Presenter: Panagiotis Xaplanteris

May 23, 2018

Presentation EuroPCR 2018

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Presenter: Hasan Jilaihawi

May 23, 2018

Presentation EuroPCR 2018

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Presenter: David E. Kandzari

May 23, 2018

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

Presentation EuroPCR 2018

PCI Statement on PCI Treatment for Chronic Coronary Syndrome

Presenter: Michael Haude

May 22, 2018

Advertisement

CE Mark Study of Transcatheter Mitral Valve Replacement for Severe Mitral Regurgitation: 30 day outcomes of the first 100 patients

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Pace Quickens for Mitral Device Innovation for Repair, Replacement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

PCI Statement on PCI Treatment for Chronic Coronary Syndrome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content